Thermo Fisher Scientific ROE 2010-2022 | TMO

Current and historical return on equity (ROE) values for Thermo Fisher Scientific (TMO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Thermo Fisher Scientific ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2022-09-30 $7.03B $43.61B 16.76%
2022-06-30 $7.44B $42.35B 18.26%
2022-03-31 $7.60B $41.02B 19.32%
2021-12-31 $7.73B $40.86B 20.40%
2021-09-30 $8.57B $38.71B 23.60%
2021-06-30 $8.60B $36.85B 24.87%
2021-03-31 $7.92B $35.06B 24.14%
2020-12-31 $6.38B $34.52B 20.44%
2020-09-30 $4.88B $31.82B 16.27%
2020-06-30 $3.71B $29.88B 12.62%
2020-03-31 $3.67B $28.56B 12.62%
2019-12-31 $3.70B $29.68B 12.81%
2019-09-30 $3.59B $29.36B 12.67%
2019-06-30 $3.54B $28.73B 12.77%
2019-03-31 $3.17B $27.69B 11.69%
2018-12-31 $2.94B $27.59B 10.98%
2018-09-30 $2.57B $26.89B 9.79%
2018-06-30 $2.39B $26.45B 9.32%
2018-03-31 $2.25B $26.12B 9.14%
2017-12-31 $2.23B $25.41B 9.44%
2017-09-30 $2.33B $24.70B 10.29%
2017-06-30 $2.27B $22.39B 10.38%
2017-03-31 $2.17B $21.80B 10.07%
2016-12-31 $2.02B $21.54B 9.48%
2016-09-30 $2.00B $21.66B 9.37%
2016-06-30 $2.00B $21.26B 9.47%
2016-03-31 $1.99B $20.92B 9.51%
2015-12-31 $1.98B $21.35B 9.54%
2015-09-30 $1.97B $20.85B 9.63%
2015-06-30 $1.97B $20.68B 9.65%
2015-03-31 $1.74B $19.92B 8.51%
2014-12-31 $1.90B $20.55B 9.23%
2014-09-30 $1.64B $20.51B 8.34%
2014-06-30 $1.48B $20.66B 7.97%
2014-03-31 $1.48B $20.43B 8.51%
2013-12-31 $1.27B $16.86B 7.87%
2013-09-30 $1.31B $16.44B 8.26%
2013-06-30 $1.28B $15.80B 8.23%
2013-03-31 $1.24B $15.60B 8.05%
2012-12-31 $1.18B $15.47B 7.70%
2012-09-30 $1.09B $15.29B 7.18%
2012-06-30 $1.07B $15.09B 7.03%
2012-03-31 $1.35B $15.29B 8.85%
2011-12-31 $1.33B $15.04B 8.69%
2011-09-30 $1.34B $15.20B 8.70%
2011-06-30 $1.34B $15.67B 8.70%
2011-03-31 $1.06B $15.26B 6.88%
2010-12-31 $1.04B $15.36B 6.72%
2010-09-30 $1.01B $15.40B 6.56%
2010-06-30 $0.96B $15.35B 6.25%
2010-03-31 $0.93B $15.48B 6.08%
2009-12-31 $0.85B $15.43B 5.58%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $216.198B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $47.210B 32.49
Alcon (ALC) Switzerland $33.483B 28.83
STERIS (STE) Ireland $18.026B 22.43
Teleflex (TFX) United States $10.579B 17.16
Fresenius Medical Care AG KGaA (FMS) Germany $9.137B 9.17
Penumbra (PEN) United States $7.442B 1781.27
Globus Medical (GMED) United States $7.143B 36.31
Integer Holdings (ITGR) United States $2.386B 19.15
Glaukos (GKOS) United States $2.248B 0.00
Nevro (NVRO) United States $1.572B 0.00
Paragon 28 (FNA) United States $1.556B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.248B 17.77
Artivion (AORT) United States $0.525B 0.00